Literature DB >> 10098787

Proteinuria is associated with persistence of antibody to streptococcal M protein in Aboriginal Australians.

A M Goodfellow1, W E Hoy, K S Sriprakash, M J Daly, M P Reeve, J D Mathews.   

Abstract

Aboriginal communities in Northern Australia with high rates of group A streptococcal (GAS) skin infection in childhood also have high rates of renal failure in adult life. In a cross-sectional study of one such high risk community, albuminuria was used as a marker of renal disease. The prevalence of albuminuria increased from 0/52 in subjects aged 10-19 years to 10/29 (32.9%) in those aged 50 or more (P < 0.001). Antibodies to streptococcal M protein, markers of past GAS infection, were present in 48/52 (92%) at ages 10-19 years, 16/32 (50%) at ages 30-39, and 20/29 (69%) in those aged 50 or more. After allowing for the age-dependencies of albuminuria and of M protein antibodies (P < 0.001) albuminuria was significantly associated with M protein antibodies (P < 0.01). Thus, 72% of adults aged 30 or more with M protein antibodies also had albuminuria, compared with only 21% of those who were seronegative. More detailed modelling suggested that although most Aboriginal people in this community developed M protein antibodies following GAS infection in childhood, the development of proteinuria was associated with the persistence of such seropositivity into adult life. The models predicted that proteinuria developed at a mean age of 30 years in seropositive persons, at 45 years in seronegative persons who were overweight, and at 62 years in seronegative persons of normal weight. We demonstrated a clear association between evidence of childhood GAS infection and individual risk of proteinuria in adult life. This study provided a strong rationale for prevention of renal disease through the more effective control of GAS skin infections in childhood and through the prevention of obesity in adult life.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098787      PMCID: PMC2809589          DOI: 10.1017/s0950268898001812

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  4 in total

1.  Benefits of swimming pools in two remote Aboriginal communities in Western Australia: intervention study.

Authors:  Deborah Lehmann; Mary T Tennant; Desiree T Silva; Daniel McAullay; Francis Lannigan; Harvey Coates; Fiona J Stanley
Journal:  BMJ       Date:  2003-08-23

2.  Seroreactivity against streptococcal DRS (distantly related to SIC) protein is a predictor for end-stage renal failure.

Authors:  Virginia A F Boon; James L Munro; George W Kan; James Burnell; Richard Speare
Journal:  Clin Vaccine Immunol       Date:  2008-08-06

Review 3.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

4.  Seroprevalence of Streptococcal Inhibitor of Complement (SIC) suggests association of streptococcal infection with chronic kidney disease.

Authors:  Mohan Ganesh Karmarkar; Gouri Pandharinath Hule; Niwrutti Khandu Hase; Preeti Rajeev Mehta; Scott Robert Walter; Kadaba Srinivasa Sriprakash
Journal:  BMC Nephrol       Date:  2013-05-06       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.